Citations

Mayo Clinic

Showing 10 of 108523 citations.

Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice
Khosravi-Maharlooei, Mohsen , Vecchione, Andrea, Danzl, Nichole , Li, Hao Wei , Nauman, Grace , Madley, Rachel, Winchester, Robert , Ruiz, Amanda , Ding, Xiaolan, Sykes, Megan , Winchester, Robert , Ruiz, Amanda , Ding, Xiaolan , Sykes, Megan , Khosravi-Maharlooei, Mohsen , Waffarn, Elizabeth , Fousteri, Georgia

eLife | July 29, 2024 | Volume: 13 | Issue: No issue available | Pages: No page available

10.7554/elife.99389 | PMID 40293219 Get It

Human immune system (HIS) mice constructed in various ways are widely used for investigations of human immune responses to pathogens, transplants, and immunotherapies. In HIS mice that generate T cells de novo from hematopoietic progenitors, T cell-dependent multisystem autoimmune disease occurs, most rapidly when the human T cells develop in the native NOD.Cg- Prkdc scid Il2rg tm1Wjl (NSG) mouse thymus, where negative selection is abnormal. Disease develops very late when human T cells develop in human fetal thymus grafts, where robust negative selection is observed. We demonstrate here that PD-1 + CD4 + peripheral (Tph) helper-like and follicular (Tfh) helper-like T cells developing in HIS mice can induce autoimmune disease. Tfh-like cells were more prominent in HIS mice with a mouse thymus, in which the highest levels of IgG were detected in plasma, compared to those with a human thymus. While circulating IgG and IgM antibodies were autoreactive to multiple mouse antigens, in vivo depletion of B cells and antibodies did not delay the development of autoimmune disease. Conversely, adoptive transfer of enriched Tfh- or Tph-like cells induced disease and autoimmunity-associated B cell phenotypes in recipient mice containing autologous human APCs without T cells. Tfh/Tph cells from mice with a human thymus expanded and induced disease more rapidly than those originating in a murine thymus, implicating HLA-restricted T cell-APC interactions in this process. Since Tfh, Tph, autoantibodies, and lymphopenia-induced proliferation (LIP) have all been implicated in various forms of human autoimmune disease, the observations here provide a platform for the further dissection of human autoimmune disease mechanisms and therapies.
Enhancing recovery from gut microbiome dysbiosis and alleviating DSS-induced colitis in mice with a consortium of rare short-chain fatty acid-producing bacteria
Ambat, Achuthan , Mattiello, Samara Paula , Kashyap, Purna , More, Sunil , Sebastian, Vanessa, Antony, Linto , Maji, Abhijit , Ghimire, Sudeep , Scaria, Joy

Gut Microbes | July 29, 2024 | Volume: 16 | Issue: 1 | Pages: No page available

10.1080/19490976.2024.2382324 | PMID 39069899 Get It

Complex Presentation of Pheochromocytoma: Hypertensive Encephalopathy and Takotsubo-Like Cardiomyopathy in a Young Female
Raavi, Lekhya , Maheshwari, Surabhi, Celik, Nafiye Busra , Garg, Pankaj , Maheshwari, Surabhi , Rastogi, Ashu , Garg, Pankaj , Garg, Nidhi

American Journal of Case Reports | July 29, 2024 | Volume: 25 | Issue: No issue available | Pages: No page available

10.12659/ajcr.944024 | PMID 39244658 Get It

Development of a tibial intraneural ganglion cyst after surgery on a peroneal intraneural ganglion in a pediatric patient: further support for the articular origin of intraneural ganglion cysts. Illustrative case
Amrami, Kimberly K. , Spinner, Robert J., Maldonado, Andrés A. , Spinner, Robert J.

Journal of Neurosurgery: Case Lessons | July 29, 2024 | Volume: 8 | Issue: 5 | Pages: No page available

10.3171/case24277 | PMID 39074386 Get It

BACKGROUND The articular origin of intraneural cysts has been previously described and well supported. Intraneural ganglion cysts most commonly occur in adults and in the common peroneal nerve arising from the anterior aspect of the superior tibiofibular joint (STFJ). OBSERVATIONS The authors report a pediatric patient who developed a tibial intraneural cyst arising from the posterior aspect of the STFJ within months after surgical treatment of a peroneal intraneural cyst from the anterior aspect of the same joint. Surgery consisted of disconnecting the articular branch of the peroneal nerve and decompression of the cyst. Three-month postoperative magnetic resonance imaging showed resolution of the peroneal intraneural cyst and anterior compartment denervation but demonstrated a clinically occult small tibial intraneural ganglion cyst arising from the STFJ with popliteus muscle atrophy. LESSONS This case underscores the importance of addressing the underlying etiology (articular synovitis) or the communication pathways (articular branches) whenever feasible to mitigate intraneural cyst recurrence. Furthermore, this report reinforces the validity of the articular theory. https://thejns.org/doi/10.3171/CASE24277
The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
Brooks, Rebecca , Luedders, Brent A. , Wheeler, Austin M. , Johnson, Tate , Yang, Yangyuna, Roul, Punyasha, Ganti, Apar Kishor , Sauer, Brian C. , Cannon, Grant W. , Brooks, Rebecca T, Luedders, Brent , Wheeler, Austin , Johnson, Tate M , Sauer, Brian C , Cannon, Grant W , Baker, Joshua F , Mikuls, Ted R , England, Bryant R , Ganti, Apar K , Singh, Namrata , Baker, Joshua F. , Mikuls, Ted R. , England, Bryant R.

Arthritis & Rheumatology | July 29, 2024 | Volume: 76 | Issue: 12 | Pages: 1730-1738

10.1002/art.42961 | PMID 39073264 Get It

ObjectiveWe aimed to evaluate lung cancer risk in patients with rheumatoid arthritis (RA) and RA‐interstitial lung disease (ILD).MethodsWe performed a retrospective, matched cohort study of RA and RA‐ILD within the Veterans Health Administration (VA) between 2000 and 2019. Patients with RA and RA‐ILD were identified with validated administrative‐based algorithms, then matched (up to 1:10) on age, gender, and VA enrollment year to individuals without RA. Lung cancers were identified from a VA oncology database and the National Death Index. Conditional Cox regression models assessed lung cancer risk adjusting for race, ethnicity, smoking status, Agent Orange exposure, and comorbidity burden among matched individuals. Several sensitivity analyses were performed.ResultsWe matched 72,795 patients with RA with 633,937 patients without RA (mean age 63 years; 88% male). Over 4,481,323 patient‐years, 17,099 incident lung cancers occurred. RA was independently associated with an increased lung cancer risk (adjusted hazard ratio [aHR] 1.58 [95% confidence interval (CI) 1.52–1.64]), which persisted in never smokers (aHR 1.65 [95% CI 1.22–2.24]) and in those with incident RA (aHR 1.54 [95% CI 1.44–1.65]). Compared to non‐RA controls, prevalent RA‐ILD (n = 757) was more strongly associated with lung cancer risk (aHR 3.25 [95% CI 2.13–4.95]) than RA without ILD (aHR 1.57 [95% CI 1.51–1.64]). Analyses of both prevalent and incident RA‐ILD produced similar results (RA‐ILD vs non‐RA aHR 2.88 [95% CI 2.45–3.40]).ConclusionRA was associated with a >50% increased risk of lung cancer, and those with RA‐ILD represented a particularly high‐risk group with an approximate three‐fold increased risk. Increased lung cancer surveillance in RA, and especially RA‐ILD, may be a useful strategy for reducing the burden posed by the leading cause of cancer death.
PP2A catalytic subunit alpha is critically required for CD8 + T‐cell homeostasis and antibacterial responses
Li, Meilu , Ai, Minji , Li, Yanfeng , Zhu, Xingxing, Hansen, Michael J. , Zhong, Jun , Johnson, Kenneth L. , Pease, Larry R. , Zeng, Hu , Zhong, Jun , Zenka, Roman, Zeng, Hu , Zhou, Xian , Zenka, Roman M. , Pandey, Akhilesh

European Journal of Immunology | July 29, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/eji.202451080 | PMID 39072720 Get It

Abstract Although the functions of tyrosine phosphatases in T‐cell biology have been extensively studied, our knowledge on the contribution of serine/threonine phosphatases in T cells remains poor. Protein phosphatase 2A (PP2A) is one of the most abundantly expressed serine/threonine phosphatases. It is important in thymocyte development and CD4 + T‐cell differentiation. Utilizing a genetic model in which its catalytic subunit alpha isoform (PP2A Cα) is deleted in T cells, we investigated its contribution to CD8 + T‐cell homeostasis and effector functions. Our results demonstrate that T‐cell intrinsic PP2A Cα is critically required for CD8 + T‐cell homeostasis in secondary lymphoid organs and intestinal mucosal site. Importantly, PP2A Cα–deficient CD8 + T cells exhibit reduced proliferation and survival. CD8 + T‐cell antibacterial response is strictly dependent on PP2A Cα. Expression of Bcl2 transgene rescues CD8 + T‐cell homeostasis in spleens, but not in intestinal mucosal site, nor does it restore defective antibacterial responses. Finally, proteomics and phosphoproteomics analyses reveal potential targets dependent on PP2A Cα, including mTORC1 and AKT. Thus, PP2A Cα is a key modulator of CD8 + T‐cell homeostasis and effector functions.
Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia
Pike, James Russell , Chen, Jinyu , Sullivan, Kevin , Thyagarajan, Bharat , Lutsey, Pamela L. , Sharrett, A. Richey, Mosley, Thomas H., Palta, Priya, Sullivan, Kevin J , Lutsey, Pamela L , Pike, James R , Thyagarajan, Bharat , Lü, Yifei , Walker, Keenan A. , Mielke, Michelle M. , Knopman, David S. , Gottesman, Rebecca F. , Coresh, Josef , Mosley, Thomas H.

JAMA | July 28, 2024 | Volume: 332 | Issue: 15 | Pages: 1258

10.1001/jama.2024.6619 | PMID 39068543 Get It

Importance Plasma biomarkers show promise for identifying Alzheimer disease (AD) neuropathology and neurodegeneration, but additional examination among diverse populations and throughout the life course is needed. Objective To assess temporal plasma biomarker changes and their association with all-cause dementia, overall and among subgroups of community-dwelling adults. Design, Setting, and Participants In 1525 participants from the US-based Atherosclerosis Risk in Communities (ARIC) study, plasma biomarkers were measured using stored specimens collected in midlife (1993-1995, mean age 58.3 years) and late life (2011-2013, mean age 76.0 years; followed up to 2016-2019, mean age 80.7 years). Midlife risk factors (hypertension, diabetes, lipids, coronary heart disease, cigarette use, and physical activity) were assessed for their associations with change in plasma biomarkers over time. The associations of biomarkers with incident all-cause dementia were evaluated in a subpopulation (n = 1339) who were dementia-free in 2011-2013 and had biomarker measurements in 1993-1995 and 2011-2013. Exposure Plasma biomarkers of amyloid-β 42 to amyloid-β 40 (Aβ42:Aβ40) ratio, phosphorylated tau at threonine 181 (p-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) were measured using the Quanterix Simoa platform. Main Outcomes and Measures Incident all-cause dementia was ascertained from January 1, 2012, through December 31, 2019, from neuropsychological assessments, semiannual participant or informant contact, and medical record surveillance. Results Among 1525 participants (mean age, 58.3 [SD, 5.1] years), 914 participants (59.9%) were women, and 394 participants (25.8%) were Black. A total of 252 participants (16.5%) developed dementia. Decreasing Aβ42:Aβ40 ratio and increasing p-tau181, NfL, and GFAP were observed from midlife to late life, with more rapid biomarker changes among participants carrying the apolipoprotein E epsilon 4 ( APOE ε4) allele. Midlife hypertension was associated with a 0.15-SD faster NfL increase and a 0.08-SD faster GFAP increase per decade; estimates for midlife diabetes were a 0.11-SD faster for NfL and 0.15-SD faster for GFAP. Only AD-specific biomarkers in midlife demonstrated long-term associations with late-life dementia (hazard ratio per SD lower Aβ42:Aβ40 ratio, 1.11; 95% CI, 1.02-1.21; per SD higher p-tau181, 1.15; 95% CI, 1.06-1.25). All plasma biomarkers in late life had statistically significant associations with late-life dementia, with NfL demonstrating the largest association (1.92; 95% CI, 1.72-2.14). Conclusions and Relevance Plasma biomarkers of AD neuropathology, neuronal injury, and astrogliosis increase with age and are associated with known dementia risk factors. AD-specific biomarkers’ association with dementia starts in midlife whereas late-life measures of AD, neuronal injury, and astrogliosis biomarkers are all associated with dementia.
Outcome of Corynebacterial Bloodstream Infection in Patients With Cardiac Implantable Electronic Devices: A Brief Report and Systematic Review
Chesdachai, Supavit , Baddour, Larry M. , Sohail, M. Rizwan , Palraj, Bharath Raj, Madhavan, Malini , Tabaja, Hussam , McGinnis, Michele , Fida, Madiha , Palraj, Raj , McGinnis, Michele T, Challener, Douglas , Baddour, Larry , Sohail, M Rizwan , Palraj, Raj , Fida, Madiha , Chesdachai, Supavit , McGinnis, Michele T , Tabaja, Hussam , Challener, Douglas W. , DeSimone, Daniel C.

Open Forum Infectious Diseases | July 27, 2024 | Volume: 11 | Issue: 8 | Pages: No page available

10.1093/ofid/ofae441 | PMID 39161858 Get It

Abstract Cardiac implantable electronic device infection in the context of corynebacterial bloodstream infection (BSI) remains poorly understood. From 2012 to 2023 at Mayo Clinic, 4 of 12 patients with corynebacterial BSI had cardiac implantable electronic device infection: 1 patient was diagnosed during a relapsing BSI episode. Undefined source, persistent BSI, and the presence of a prosthetic cardiac valve were common characteristics.
Risk‐adapted treatment in multiple myeloma: Does more make it merrier?
Zanwar, Saurabh , Sborov, Douglas W. , Sborov, Douglas W , Fortuna, Gliceida Galarza

British Journal of Haematology | July 27, 2024 | Volume: 205 | Issue: 3 | Pages: 767-769

10.1111/bjh.19676 | PMID 39072706 Get It

Kaiser et al. offer management recommendations for transplant‐eligible, high‐risk multiple myeloma (HRMM), derived from recent trials exploring treatment intensification in the various phases of front‐line therapy. The definition of HRMM continues to evolve with emergence of novel genomic insights and impact of modern therapies, underscoring the need to expand beyond traditional interphase fluorescence in situ hybridization cytogenetics and International Staging System staging for a precise risk assessment. Despite progress, ongoing challenges in treatment delivery and tolerability underscore the urgency for exploring novel approaches like T‐cell redirecting bispecific antibodies and chimeric antigen receptor T‐cell to enhance outcomes in this complex patient population.Commentary on: Kaiser et al. Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper. Br J Haematol 2024; 205:833‐839.
Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals
Snozek, Christine L.H. , Yee, Claire I., Bryksin, Janetta, Dahal, Rejwi , Gerson, Benjamin, Gherasim, Carmen , Heger, Nicholas E. , Johnson‐Davis, Kamisha L. , Knezevic, Claire E. , Love, Sara A., Noguez, Jaime H. , Pikulski, Michael, Tyagi, Manoj , Warrington, Jill S. , Yang, He S. , Yang, Yifei , Knezevic, Claire E , Roper, Stephen , Yang, Yifei K, Hauff, Kristin D. , Huestis, Marilyn Ann , Melanson, Stacy E.F. , Roper, Stephen M. , Tyagi, Manoj

American Journal of Clinical Pathology | July 27, 2024 | Volume: 163 | Issue: 1 | Pages: 69-79

10.1093/ajcp/aqae095 | PMID 39066575 Get It

Abstract Objectives Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability of health care professionals to interpret UDT results accurately. Methods In total, 911 clinical and laboratory professionals in the United States and Canada responded to a survey with questions gauging expertise in UDT interpretation. Responses were analyzed to identify knowledge gaps. Results Toxicologists and laboratory PhD scientists performed well, with means of 4.82 and 4.63 questions answered correctly (out of 6 possible), respectively. Physicians specializing in pathology, emergency medicine, primary care, and internal medicine, however, displayed concerning knowledge gaps, as did laboratorians with nondoctoral degrees. Experience and training correlated with interpretation accuracy. Identification of simulated compliance as well as understanding opioid exposure, metabolism, and immunoassay cross-reactivity were among the most clinically significant knowledge gaps. More than 30% of survey respondents indicated that they would seek UDT information from the internet or peers rather than clinical or laboratory experts. Conclusions The study highlighted the need for targeted education and better collaboration between clinical and laboratory experts and other health care professionals to ensure that when physicians order UDT, they can accurately interpret results and reduce harm.